However, our data in the adoptive T cell transfer-mediated colitis model and in vitro T cell polyclonal experiments showed no significant differences in the differentiation and activation of CD9-deficient and WT Th1 and Th17 T cell subsets. This evidence concerns the gene CD9 and colitis.